Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

DDB2: a novel regulator of NF-κB and breast tumor invasion.

Ennen M, Klotz R, Touche N, Pinel S, Barbieux C, Besancenot V, Brunner E, Thiebaut D, Jung AC, Ledrappier S, Domenjoud L, Abecassis J, Plénat F, Grandemange S, Becuwe P.

Cancer Res. 2013 Aug 15;73(16):5040-52. doi: 10.1158/0008-5472.CAN-12-3655. Epub 2013 Jun 17.

2.

Regulation of the high basal expression of the manganese superoxide dismutase gene in aggressive breast cancer cells.

Ennen M, Minig V, Grandemange S, Touche N, Merlin JL, Besancenot V, Brunner E, Domenjoud L, Becuwe P.

Free Radic Biol Med. 2011 Jun 15;50(12):1771-9. doi: 10.1016/j.freeradbiomed.2011.03.013. Epub 2011 Mar 16.

PMID:
21419216
3.

Identification of DDB2 protein as a transcriptional regulator of constitutive SOD2 gene expression in human breast cancer cells.

Minig V, Kattan Z, van Beeumen J, Brunner E, Becuwe P.

J Biol Chem. 2009 May 22;284(21):14165-76. doi: 10.1074/jbc.M808208200. Epub 2009 Apr 1.

5.

Celastrol inhibits breast cancer cell invasion via suppression of NF-ĸB-mediated matrix metalloproteinase-9 expression.

Kim Y, Kang H, Jang SW, Ko J.

Cell Physiol Biochem. 2011;28(2):175-84. doi: 10.1159/000331729. Epub 2011 Aug 16.

PMID:
21865725
6.

Testes-specific protease 50 promotes cell invasion and metastasis by increasing NF-kappaB-dependent matrix metalloproteinase-9 expression.

Song ZB, Ni JS, Wu P, Bao YL, Liu T, Li M, Fan C, Zhang WJ, Sun LG, Huang YX, Li YX.

Cell Death Dis. 2015 Mar 26;6:e1703. doi: 10.1038/cddis.2015.61.

7.

bcl-2 over-expression enhances NF-kappaB activity and induces mmp-9 transcription in human MCF7(ADR) breast-cancer cells.

Ricca A, Biroccio A, Del Bufalo D, Mackay AR, Santoni A, Cippitelli M.

Int J Cancer. 2000 Apr 15;86(2):188-96.

8.

Induction of heme oxygenase-1 and inhibition of TPA-induced matrix metalloproteinase-9 expression by andrographolide in MCF-7 human breast cancer cells.

Chao CY, Lii CK, Hsu YT, Lu CY, Liu KL, Li CC, Chen HW.

Carcinogenesis. 2013 Aug;34(8):1843-51. doi: 10.1093/carcin/bgt131. Epub 2013 Apr 24.

9.

NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells.

Bendinelli P, Matteucci E, Maroni P, Desiderio MA.

Mol Cancer Res. 2009 Aug;7(8):1328-41. doi: 10.1158/1541-7786.MCR-08-0548. Epub 2009 Aug 11.

10.

NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4.

Helbig G, Christopherson KW 2nd, Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD, Broxmeyer HE, Nakshatri H.

J Biol Chem. 2003 Jun 13;278(24):21631-8. Epub 2003 Apr 9.

11.

Damaged DNA binding protein 2 plays a role in breast cancer cell growth.

Kattan Z, Marchal S, Brunner E, Ramacci C, Leroux A, Merlin JL, Domenjoud L, Dauça M, Becuwe P.

PLoS One. 2008 Apr 23;3(4):e2002. doi: 10.1371/journal.pone.0002002.

12.
13.

S100A7 enhances invasion of human breast cancer MDA-MB-468 cells through activation of nuclear factor-κB signaling.

Liu H, Wang L, Wang X, Cao Z, Yang Q, Zhang K.

World J Surg Oncol. 2013 Apr 23;11:93. doi: 10.1186/1477-7819-11-93.

14.

EpCAM modulates NF-κB signaling and interleukin-8 expression in breast cancer.

Sankpal NV, Fleming TP, Gillanders WE.

Mol Cancer Res. 2013 Apr;11(4):418-26. doi: 10.1158/1541-7786.MCR-12-0518. Epub 2013 Feb 1.

15.

Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-κB-dependent matrix metalloproteinase-9 expression.

Ling H, Zhang Y, Ng KY, Chew EH.

Breast Cancer Res Treat. 2011 Apr;126(3):609-20. doi: 10.1007/s10549-010-0929-5. Epub 2010 Jun 3.

PMID:
20521099
16.

Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways.

Ahmad A, Wang Z, Kong D, Ali R, Ali S, Banerjee S, Sarkar FH.

Breast Cancer Res Treat. 2011 Feb;126(1):15-25. doi: 10.1007/s10549-010-0883-2. Epub 2010 Apr 9.

PMID:
20379844
17.

Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.

Patel NM, Nozaki S, Shortle NH, Bhat-Nakshatri P, Newton TR, Rice S, Gelfanov V, Boswell SH, Goulet RJ Jr, Sledge GW Jr, Nakshatri H.

Oncogene. 2000 Aug 24;19(36):4159-69.

18.

Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth.

Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ Jr, Sledge GW Jr.

Mol Cell Biol. 1997 Jul;17(7):3629-39.

19.

Transforming growth factor-beta1-mediated activation of NF-kappaB contributes to enhanced ADAM-12 expression in mammary carcinoma cells.

Ray A, Dhar S, Ray BK.

Mol Cancer Res. 2010 Sep;8(9):1261-70. doi: 10.1158/1541-7786.MCR-10-0212. Epub 2010 Aug 5.

20.

Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer.

Yuan SS, Hou MF, Hsieh YC, Huang CY, Lee YC, Chen YJ, Lo S.

J Natl Cancer Inst. 2012 Oct 3;104(19):1485-502. doi: 10.1093/jnci/djs355. Epub 2012 Aug 22.

Items per page

Supplemental Content

Write to the Help Desk